Purchase Order HHSN272201501317P
Award Date 9/14/15
Potential Completion Date 9/30/15
Potential Value $6.6K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $3,500 firm-fixed-price delivery order awarded to Advanced Bioscience Laboratories, Inc. (ABL) by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health. The order is under the NIAID's Diagnostics Pre-Clinical Services Program Indefinite Delivery Vehicle (IDV), which has a total ceiling value of $24 million. ABL, a foreign-owned, for-profit manufacturer, is providing a range of preclinical development services to support...
- This is a federal contract award to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit manufacturer of goods, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract, valued at $1,826,332.06, is for the provision of preclinical development support services related to the NIAID's infectious disease research and product development...
- This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL). The $13,047,649.73 contract is for "ESSENTIAL CORE ACTIVITIES, NIAID PRECLIN DEVELOPMENT SUPPORT" and does not have a set-aside designation. ABL is a foreign-owned, for-profit manufacturing company that specializes in the development of gene...
- This is a definitive, cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit manufacturer of goods. The contract, valued at $213,045,738.00, is for preclinical development services to support infectious disease research and product development initiatives. The contract does not have a set-aside designation. ABL has been awarded numerous federal contracts and grants,...
- This federal contract award, valued at $3,500.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL) under the Diagnostics Pre-Clinical Services Program Indefinite Delivery/Indefinite Quantity (IDIQ) contract. The contract has a period of performance through June 19, 2030 and is a Firm Fixed Price delivery order. ABL, a foreign-owned, for-profit manufacturer of goods, will provide a range of preclinical services to...
- This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL). The contract is for $1,812,395.46 and provides for the manufacture and characterization of vaccines and other biologics. The contract does not have a set-aside designation. ABL is a foreign-owned, for-profit organization that specializes in the development of gene...
- This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a large for-profit manufacturer of goods. The contract, titled "ESSENTIAL CORE ACTIVITIES III," has a ceiling value of $1,920,166.00 and an ultimate completion date of June 8, 2029. This contract is not set aside for any specific business...
- This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Advanced Bioscience Laboratories, Inc. (ABL). The contract, with a ceiling value of $186,316.03, is for the manufacture and characterization of vaccines and other biologics. ABL, a foreign-owned, for-profit organization that specializes in biopharmaceutical research and development, is a leading contract research and manufacturing...
- This is a prime contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL) on September 20, 2017. The contract has a potential value of $2,044,103.00 and is a Delivery Order for NIAID Preclinical Development Support services. The contract has a completion date of December 31, 2022 and is not set-aside. ABL is a contract research and...
- This is a federal contract award made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL). The contract is for "Manufacture and Characterization Services (MCS) for Vaccines and Other Biologics for Infectious Diseases" and has a ceiling value of $1,672,101.05. It is a cost-plus-fixed-fee delivery order contract with a period of performance through July 2022....